The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. FDA to weigh easing limits on unproven peptides promoted by RFK Jr.